Company Overview

Owlet, Inc. is a U.S.-based digital health and consumer technology company focused on connected infant monitoring products and pediatric health data solutions. The company operates primarily in the consumer health technology and medical device sectors, combining hardware, software, and data analytics to help parents monitor infant wellness indicators such as heart rate, oxygen saturation, sleep trends, and movement. Owlet’s core offerings include the Dream Sock, Owlet Cam, and related subscription-based digital services delivered through the Owlet mobile application ecosystem.

The company generates revenue primarily through sales of connected monitoring devices, accessories, and digital health services. Owlet initially gained market attention through wearable infant-monitoring technology designed for home use and later expanded into regulated healthcare-oriented products after pursuing U.S. Food and Drug Administration clearance pathways for certain monitoring devices. The company was founded in 2013 and evolved from a startup focused on consumer infant wearables into a broader pediatric digital health platform with operations spanning retail, direct-to-consumer sales, and healthcare-related monitoring initiatives.

Business Operations

Owlet conducts operations through a unified connected-care model centered on hardware devices, cloud-connected software infrastructure, and mobile applications. Its principal revenue streams include sales of the Dream Sock wearable monitoring platform, camera-based monitoring products under the Owlet Cam brand, subscription services, and related accessories. The company distributes products through direct online channels and retail partnerships with major North American and international retailers. Owlet has also pursued healthcare integration initiatives involving remote patient monitoring and physician-connected infant monitoring applications.

The company operates primarily in the United States, while maintaining growing international distribution across select markets in Europe, Asia-Pacific, and other regions. Owlet controls proprietary monitoring technology, mobile software systems, data analytics capabilities, and connected-device intellectual property supporting its wearable ecosystem. Historically, the company has relied on manufacturing partnerships and third-party supply chain providers for hardware production. Public filings and investor materials identify strategic collaborations with healthcare institutions, retail distribution partners, and regulatory agencies related to pediatric monitoring technologies.

Strategic Position & Investments

Owlet’s strategic direction has focused on expanding from consumer infant monitoring into broader regulated pediatric health technology and recurring digital health services. Key growth initiatives have included obtaining regulatory clearances for monitoring devices, expanding subscription and app-based engagement, increasing international distribution, and improving product reliability and clinical positioning. The company has emphasized data-driven pediatric monitoring capabilities as a differentiating factor within the connected health market.

A significant milestone in Owlet’s corporate development was its public market debut through a merger with special purpose acquisition company Sandbridge Acquisition Corporation in 2021. Since becoming publicly traded, the company has concentrated investments on product innovation, regulatory compliance, software platform development, and international market expansion. Owlet has also invested in artificial intelligence-enhanced analytics, connected health infrastructure, and digital patient monitoring initiatives intended to strengthen long-term positioning within pediatric health technology and remote monitoring sectors.

Geographic Footprint

Owlet is headquartered in Lehi, Utah, and maintains its primary operational presence in the United States. The company distributes products across multiple international markets through retail partnerships, e-commerce channels, and regional distributors. Public disclosures indicate commercial activity in parts of North America, Europe, the Middle East, and the Asia-Pacific region, although revenue concentration remains weighted toward the U.S. market.

International expansion has been a recurring strategic focus, particularly in regions with established demand for connected consumer health products and infant monitoring solutions. The company’s global footprint includes localized product certifications, regional distribution agreements, and international regulatory engagement to support market access outside the United States. Available public information indicates that Owlet continues evaluating broader international growth opportunities while balancing regulatory and operational requirements.

Leadership & Governance

Owlet was co-founded by a group of entrepreneurs and product developers focused on applying wearable sensor technology to infant monitoring. Leadership has consistently emphasized innovation in connected pediatric care, data-enabled parenting tools, and integration between consumer technology and healthcare monitoring systems. Corporate governance is overseen by a board of directors and executive leadership team responsible for regulatory strategy, product development, commercialization, and financial management.

Key executives identified in recent public filings and investor disclosures include:

• Kurt Workman – Co-Founder and Executive Chairman
• Jonathan Harris – Chief Executive Officer
• Amanda Twede Crawford – Chief Financial Officer
• Patricia Dabrowiak – Chief Commercial Officer
• Chris Bruce – Chief Technology Officer

Leadership communications in public filings and investor materials have consistently highlighted product innovation, regulatory advancement, operational discipline, and expansion of recurring digital health revenue opportunities as central components of the company’s strategic vision.